Table 1.

Patient demographic characteristics, baseline characteristics, and numbers of bleeding events for all patients (N = 102)

Characteristic	Value
Sex, N (%)
Female	43 (42)
Male	59 (58)
Age, median (range), y	74 (26-97)
Underlying disorders, N (%)
None/idiopathic	68 (67)
Autoimmunity	20 (20)
Malignancy	13 (13)
Pregnancy	5 (5)
Concomitant disorders, N (%)
Coronary artery disease	28 (27)
Heart failure	30 (29)
Renal failure	37 (36)
Arterial hypertension	59 (58)
Type 2 diabetes	28 (27)
WHO performance status, N (%)
0	15 (15)
1	26 (25)
2	23 (23)
3	22 (22)
4	15 (15)
5	1 (1)
Baseline FVIII activity, median (range), IU/dL	1.4 (<1-31)
Inhibitor, median (range), BU/mL	19 (1-1449)
Bleeding events, no. of events/no. of patients
All events	289/93
Events before or on day 1	148/80
Events after day 1	141/61

Part of this information has been included in a previous publication of the GTH-AH 01/2010 study.¹⁰